Enanta Pharmaceuticals Congress Trades
NASDAQ: ENTAHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0
- Sales
- 0
- Politicians trading
- 0
- Latest trade
- Jul 12, 2023
Enanta Pharmaceuticals Congress trading summary
Members of Congress have disclosed 1 transaction in Enanta Pharmaceuticals (ENTA) stock, reported by 1 politician. No ENTA trades were reported with a transaction date in the past 12 months. The most active trader is Rep. Daniel S. Goldman (1).
The latest reported trade is a sale by Daniel S. Goldman dated Jul 12, 2023 and disclosed on Aug 13, 2023. The most common reported amount is $1,001 – $15,000; disclosures list value ranges, not exact amounts.
Summary generated from market data by MetaCap's automated system. Methodology
Politicians trading ENTA
ENTA trades by members of Congress
| Politician | Type | Amount | Traded | Filing |
|---|---|---|---|---|
 Daniel S. GoldmanD-NYHouse | Sell | $1,001 – $15,000 | Jul 12, 2023 | Filing for Daniel S. Goldman ENTA trade |
Source: House Clerk and Senate EFD public disclosures. Trades are reported as dollar ranges and may be disclosed up to 45 days after the transaction.
Related
Source: House Clerk and Senate EFD public disclosures. Trades are reported as dollar ranges and may be disclosed up to 45 days after the transaction. Disclosures are shown as filed and are not a recommendation to buy or sell ENTA. How Congress trading data works